Netflix stock soars after strong subscriber gains, Oracle teams with OpenAI and SoftBank in a $500 billion AI infrastructure partnership, and Johnson & Johnson falls after mixed guidance.

Trump inauguration, Q4 earnings season will be in focus in the holiday-shortened week ahead. • With its transformative business model and clear growth trajectory, Netflix looks like a compelling buy for investors seeking quality growth.

Novo Nordisk shares surged on the results of a new obesity-drug study Friday. The Danish pharmaceutical giant behind Ozempic and Wegovy said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.